Marc J Nieuwenhuijse , research fellow ICOR and FDA 1 2 3 , R G H H Nelissen , professor 2 , J W Schoones , information specialist 4 , A Sedrakyan , associate professor 1 3 1 Patient Centered Comparative Effectiveness Program and US Food and Drug ... British Medical Journal, 1 week ago
3 images for "fda centre for drug evaluation and research"
Pfizer seeks US FDA nod for palbociclib in combo with letrozole to treat women with ER+, HER2- advanced breast cancer
Pfizer has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (US FDA) for palbociclib. This NDA requests FDA approval of palbociclib, in combination with letrozole, for the treatment of ...PharmaBiz, 1 month ago
Woman with alopecia, for which there is currently no cure or treatment (Lovebug11768) A drug approved by the US Food and Drugs Administration has been found to "cure" alopecia in just a few months. Ruxolitinib is a Janus kinase inhibitor, also ...International Business Times UK, 1 month ago
The US Food and Drug Administration (FDA) has issued a draft guidance for the pharma and biotechnology industry to provide regulatory submissions in electronic format. This would be related to certain human pharmaceutical product applications. The ...PharmaBiz, 1 month ago
Key evaluation to inform the US Food and Drug Administration regulatory submission Prominent urology trials consortium The CUSP Group LLC to oversee study of the MiStat technology Initial pilot investigation will be followed by larger pivotal ...Asian Hospital & Healthcare Management, 2 days ago
NEW YORK, Sept. 4, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: This BCC Research report provides detailed product analyses within health and wellness subsegments to overall ...Reliance Trust, 2 weeks ago Needle-Free Delivery: Technology and Market Forecast 2014-2024 Biotechgate, 3 weeks ago
GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)
1 min ago Related Stocks GSK - Glaxosmithkline Plc LONDON , Aug. 26, 2014 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug ...Barchart, 3 weeks ago
ATLANTA, July 17 —The United States Food and Drug Administration (FDA) confirmed that more vials of contagious viruses have been uncovered in the same storage room where six long-lost vials of smallpox virus were discovered last week. The vials ...Malay Mail, 2 months ago
Amgen presents data from phase 3 SHIFT study evaluating ivabradine in patients with chronic HF at HFSA
Amgen announced data from the phase 3 SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18th Annual Scientific Meeting of the ...PharmaBiz, 5 days ago
The World Health Organization today concluded its two-day meeting of 200 researchers who aim to speed up development of experimental drugs and vaccines to fight the Ebola outbreak in West Africa. WHO assistant directorgeneral Marie Paule Kieny ...CBC, 2 weeks ago Ebola crisis: WHO discusses experimental drugs CBC, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!